SIRT5 promotes non-small cell lung cancer progression by reducing FABP4 acetylation level.
Sign Up to like & getrecommendations! Published in 2022 at "Neoplasma"
DOI: 10.4149/neo_2022_220107n28
Abstract: This study evaluates the role of SIRT5 in non-small cell lung cancer (NSCLC) progression and explores the underlying mechanism. The expression and correlation of SIRT5 and FABP4 in lung cancer were analyzed by the GEPIA… read more here.
Keywords: sirt5; sirt5 fabp4; lung cancer; cell ... See more keywords